Eric Swayze
About Eric Swayze
Eric E. Swayze, Ph.D., is an accomplished chemist and executive, currently serving as the Executive Vice President of Research, with a significant track record in drug discovery and technology development in the pharmaceutical industry.
Eric E. Swayze, Ph.D. - Executive Vice President, Research
Eric E. Swayze, Ph.D., holds the position of Executive Vice President, Research at Ionis. With a distinguished career in the pharmaceutical industry, Dr. Swayze has been pivotal in driving key research initiatives and fostering innovation within the company. His leadership spans numerous high-impact projects and technological advancements.
Ph.D. in Organic Chemistry from University of Michigan
Dr. Eric E. Swayze earned his Ph.D. in Organic Chemistry at the University of Michigan. His doctoral research was conducted under the guidance of Professor Leroy B. Townsend, where he developed in-depth expertise in organic chemistry. This robust academic foundation has contributed significantly to his successes in the pharmaceutical field.
Former Vice President of Chemistry and Neuroscience Drug Discovery at Ionis
Before his role as Executive Vice President, Research, Dr. Swayze served as the Vice President of Chemistry and Neuroscience Drug Discovery at Ionis. In this capacity, he managed the progression of multiple drug discovery programs into clinical development, significantly impacting the company's research trajectory.
Key Contributions: Generation 2.5 Chemistry and LICA Technology
Since joining Ionis in 1994, Dr. Swayze has been instrumental in advancing critical technologies. Notably, he has contributed to the development of Ionis' Generation 2.5 chemistry and Ligand-Conjugated Antisense (LICA) technology, both of which have had far-reaching implications for therapeutic innovation.
Author and Inventor with Over 150 Scientific Manuscripts and 140 Patents
Dr. Swayze's prolific contributions to scientific literature and innovation are reflected in his authorship of more than 150 scientific manuscripts, several reviews, and book chapters. Additionally, he is the inventor of more than 140 issued US patents, underscoring his significant influence on pharmaceutical research and development.